Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-18 | Dec-31-17 |
| Revenues | 37.7 | 131.6 | 89.8 | 88.9 |
| Revenue growth | -71.3% | | 1.0% | |
| Cost of goods sold | 31.8 | 115.1 | 80.6 | 78.3 |
| Gross profit | 5.9 | 16.4 | 9.3 | 10.6 |
| Gross margin | 15.8% | 12.5% | 10.3% | 11.9% |
| Sales and marketing | 1.2 | 1.3 | 3.4 | 3.3 |
| Research and development | | | 30.9 | 55.0 |
| General and administrative | 10.9 | 11.5 | 16.8 | 15.5 |
| EBIT | -5.9 | 3.8 | -11.4 | -9.5 |
| EBIT margin | -15.6% | 2.9% | -12.7% | -10.7% |
| Pre-tax income | -3.6 | 2.4 | -14.7 | -11.0 |
| Income taxes | -0.3 | 1.5 | 0.0 | 1.1 |
| Tax rate | 8.3% | 61.0% | 0.0% | |
| Net income | -3.3 | 1.0 | -14.6 | -11.9 |
| Net margin | -8.8% | 0.7% | -16.3% | -13.4% |
| |
| Diluted EPS | ($0.08) | $0.02 | ($0.22) | ($0.18) |
| Shares outstanding (diluted) | 39.7 | 40.0 | 66.3 | 65.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|